In a Kaiser Health News story about insurance obstacles for birth control, Willi Horner-Johnson, Ph.D., says women have described being treated like children or having to go to multiple doctors to find someone with whom they felt comfortable when seeking contraception. The story was picked up by news outlets across the country.

A commonly used scientific method to analyze a tiny amount of DNA in early human embryos fails to accurately reflect gene edits, according to new research from OHSU presented this week at the Third International Summit on Human Genome Editing in London. Shoukhrat Mitalipov, Ph.D., says, “Gene repair has great potential, but these new results show that we have a lot of work to do”

A commonly used scientific method to analyze a tiny amount of DNA in early human embryos fails to accurately reflect gene edits, according to new research from OHSU presented this week at the Third International Summit on Human Genome Editing in London. Shoukhrat Mitalipov, Ph.D., says, “Gene repair has great potential, but these new results show that we have a lot of work to do.”

BioPharma Dive covers a debate over the safety and effectiveness of a medication to prevent preterm labor; Aaron Caughey, M.D., Ph.D., says, “I would offer it and discuss with patients the evidence that we have, which is imperfect at the current time, and allow it to be what we call a ‘shared medical decision-making opportunity’ between the patient and the provider.”

Ahmad Masri, M.D., reports results from a Phase 2 trial that found the medication aficamten improves symptoms for patients with non-obstructive hypertrophic cardiomyopathy.

NPR previews the ethical dilemmas around germline gene editing and also lays out the case for action; Mitalipov says, “There are more than 10,000 single genetic mutations that collectively affect probably hundreds of millions of people around the world. We could help a lot of people.”

Liana Tsikitis, M.D., discusses the importance of early screening for colorectal cancer in an American College of Surgeons news article; she says: “Screening is always better than no screening. A good discussion between the patient and their primary care physician can lead to what is best for the patient at the time.”

A team led by Eneida Nemecek, M.D., M.B.A., receives a grant from Genentech designed to increase diversity in cancer clinical trials. Nemecek says: “With this project, we aim to develop a framework to optimize the experience and access to cancer care and clinical trials for Hispanic/Latino patients in Oregon. We hope lessons learned from this project will inform similar future projects for other underrepresented groups in our community and beyond.”

An The Oregonian article discusses President Biden’s recent diagnosis of basal cell carcinoma, citing data from OHSU that basal and squamous cell carcinomas make up more than 95% of skin cancers.

El equipo SVO buscó patrones en sus bases de datos sobre autos robados para enfocar mejor sus esfuerzos. Luego, en noviembre del año pasado, también recurrieron al Dr. Jeffrey W. Tyner, Ph.D., científico y profesor de la Escuela de Medicina del Instituto del Cáncer Knight de OHSU, para que les ayudara a saber cómo utilizar mejor los datos.